GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma
Clinical trial NCT05242146 · TERMINATED
Trial details
- NCT number
- NCT05242146
- Sponsor
- GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2023-05-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.